Dr Oscar Rueda

June 16, 2020

Oscar’s work focuses on the development of statistical methods and models for the analysis and integration of breast cancer high-throughput data. He was part of the METABRIC group that redefined the taxonomy of breast cancer into 10 new subtypes with different driver genes.

 

Dr Oscar Rueda
Connect

Connect with us

The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.

Find out more

Connect